BANGKOK, May 24, 2023 /PRNewswire/ A research team at the Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, has identified "highly effective antibodies against COVID-19" from the human body. These antibodies have been developed into an innovation called "COVITRAP," the world's first nasal spray that traps and inhibits the COVID-19 virus using antibodies. This spray has been certified as a medical device, and the team is confident in its efficacy for dealing with COVID-19 alongside other preventive measures. Although preventive measures for COVID-19 have been relaxed to the point that mask-wearing is not required in some public places, it does not mean that COVID-19 has been entirely eliminated. The virus continues to spread and infect people, making it necessary to remain vigilant and cautious regarding infection prevention, healthcare, vaccination, and mask-wearing. But how beneficial would it be if we had help stopping CO
Lambda-Variante: kein Grund zur Aufregung, aber zur Wachsamkeit
br.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from br.de Daily Mail and Mail on Sunday newspapers.
Darum ist die Lambda-Variante kein Grund zur Aufregung
br.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from br.de Daily Mail and Mail on Sunday newspapers.
SARS-CoV-2: Escape-Varianten unempfindlich gegen Covid-Antikörper | PZ – Pharmazeutische Zeitung
pharmazeutische-zeitung.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmazeutische-zeitung.de Daily Mail and Mail on Sunday newspapers.
Corona-Infektion schützt Ältere nicht zuverlässig vor erneuter Ansteckung
spiegel.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spiegel.de Daily Mail and Mail on Sunday newspapers.